News News

February 19, 2020 Hunt for New Coronavirus Treatments Includes Gene-Silencing and Monoclonal Antibodies

Viral infections can be very hard to treat. Just ask anyone who has a bad case of…

February 10, 2020 Sirnaomics’ siRNA Therapeutic Candidate, STP705, Granted Orphan Drug Designation By US FDA for Treatment of Hepatocellular Carcinoma

Sirnaomics, Inc., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the…

January 28, 2020 Sirnaomics to develop RNAi-based therapeutics for 2019-nCoV infections

The outbreak of 2019-nCov infection, which causes respiratory illness, was first detected in Wuhan City, China, and…

Coronavirus 1
January 27, 2020 Coronavirus: AbbVie and Sirnaomics drug candidates explored for Covid-19

Amid the search for cure and treatments, China is testing the use of AbbVie’s HIV drugs to…

Wuhan
January 24, 2020 Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV

January 24, 2020 Sirnaomics Inc. (“Sirnaomics”), a leading biopharmaceutical company in discovery and development of novel RNAi…

January 13, 2020 Sirnaomics and Junshi Biosciences Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining Tuoyi and RNAi in China and US

Sirnaomics Inc. (“Sirnaomics”), a leading biopharmaceutical company in discovery and development of RNAi therapeutics against cancer and…

1 3 4 5 6 7 12